Whole Genome and Exome Sequencing Market

Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
Whole Genome and Exome Sequencing Market aims to provide a comprehensive presentation of the global market for Whole Genome and Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Genome and Exome Sequencing. Whole Genome and Exome Sequencing Market contains market size and forecasts of Whole Genome and Exome Sequencing in global, including the following market information:
Global Whole Genome and Exome Sequencing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Whole Genome and Exome Sequencing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Product Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Whole Genome and Exome Sequencing include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Novogene Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Whole Genome and Exome Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Whole Genome and Exome Sequencing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Whole Genome and Exome Sequencing Market Segment Percentages, by Type, 2022 (%)
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Global Whole Genome and Exome Sequencing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Whole Genome and Exome Sequencing Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
Global Whole Genome and Exome Sequencing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Whole Genome and Exome Sequencing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Whole Genome and Exome Sequencing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Whole Genome and Exome Sequencing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Whole Genome and Exome Sequencing, market overview.
Chapter 2: Global Whole Genome and Exome Sequencing market size in revenue.
Chapter 3: Detailed analysis of Whole Genome and Exome Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Whole Genome and Exome Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.